Home Applications 200892 Application 200892
Type ANDA
Sponsor HERITAGE PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE;ORAL 250MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A200892-001 ETHOSUXIMIDE ETHOSUXIMIDE 250MG CAPSULE / ORAL 2012-09-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL AB 2012-09-25 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A200892-001 ETHOSUXIMIDE 250MG CAPSULE / ORAL BX 2012-09-25 cb3db0bc1861…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 23155-532 ETHOSUXIMIDE ETHOSUXIMIDE Heritage Pharmaceuticals Inc. ANDA Current 23155-532 ETHOSUXIMIDE ETHOSUXIMIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. ANDA Current 23155-532 ETHOSUXIMIDE ETHOSUXIMIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. ANDA Current 68382-443 ethosuximide ethosuximide Zydus Pharmaceuticals (USA) Inc. ANDA Current